Cargando…

Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer

The activation of Janus kinase 1 (JAK1) has been reported to occur in non-small cell lung cancer (NSCLC), activating the JAK/signal transducers and activators of transcription cascade. However, the association between JAK1 activation and the prognostic value in NSCLC remains unclear. The present stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dan, Huang, Yi, Zhang, Li, Liang, Dong-Ni, Li, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620486/ https://www.ncbi.nlm.nih.gov/pubmed/28989534 http://dx.doi.org/10.3892/ol.2017.6690

Ejemplares similares

High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer
por: Liu, Dan, et al.
Publicado: (2017)

MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer
por: Guo, Zhihua, et al.
Publicado: (2017)

Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion
por: Cai, Songwang, et al.
Publicado: (2015)

GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
por: Feng, Yong, et al.
Publicado: (2022)

MARCH8 is associated with poor prognosis in non-small cell lung cancers patients
por: Fan, Jiye, et al.
Publicado: (2017)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis
por: Wang, Zhao, et al.
Publicado: (2019)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis
por: Sun, Qian, et al.
Publicado: (2018)

Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
por: Huo, Rongxiu, et al.
Publicado: (2022)

Structural basis of Janus kinase trans-activation
por: Caveney, Nathanael A., et al.
Publicado: (2023)

High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer
por: Jiang, Chao, et al.
Publicado: (2018)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway
por: Yang, Cheng-Liang, et al.
Publicado: (2012)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer
por: Ma, Weijie, et al.
Publicado: (2023)

Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non‐small cell lung cancer patients
por: Liao, Li, et al.
Publicado: (2019)

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer
por: Li, Yunxia, et al.
Publicado: (2018)

Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer
por: Xu, Weizhen, et al.
Publicado: (2015)

Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
por: Li, Boheng, et al.
Publicado: (2021)

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)

FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
por: Feng, Jian, et al.
Publicado: (2012)

Polo‐like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non‐small cell lung cancer
por: Zhou, Qin, et al.
Publicado: (2019)

Increased expression of the RNA-binding motif protein 47 predicts poor prognosis in non-small-cell lung cancer
por: Li, Ruilei, et al.
Publicado: (2020)

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
por: Zeng, Jing, et al.
Publicado: (2014)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib
por: Ni, Han, et al.
Publicado: (2013)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma
por: Huang, Xiaoyue, et al.
Publicado: (2022)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020)

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2016)

Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer
por: Wang, Qiang, et al.
Publicado: (2015)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_26jrkta6cidde35hbj0eo4oi9a